Literature DB >> 17969209

Postoperative hyperbilirubinemia and graft outcome in living donor liver transplantation.

Shigeru Marubashi1, Keizo Dono, Hiroaki Nagano, Tadafumi Asaoka, Naoki Hama, Shogo Kobayashi, Atsushi Miyamoto, Yutaka Takeda, Koji Umeshita, Morito Monden.   

Abstract

Little information is available on the characteristics and clinical significance of serum bilirubin level early after liver transplantation. The aim of this study was to clarify the risk factors for early graft loss and to assess the significance of postoperative hyperbilirubinemia as a predictor of graft outcome in living donor liver transplantation (LDLT). We retrospectively analyzed perioperative parameters in 68 patients who underwent LDLT. Graft loss within 1 year post-LDLT was confirmed in 9 patients (13.4%). Univariate analysis of risk factors showed that preoperative Model for End-Stage Liver Disease score, donor age, postoperative peak serum bilirubin level (p-BIL) within 28 days after LDLT, and surgical complications were significant determinants of early graft loss (<1 year post-transplant). Multivariate analysis identified p-BIL (odds ratio = 1.170, 95% confidence interval = 1.030-1.329, P = 0.016) as the only independent predictor of early graft loss. The incidence of such loss was high in patients with p-BIL over 27.0 mg/dL (area under the receiver operating characteristic curve = 0.988). In conclusion, serum bilirubin level is a useful predictor of short-term (<1 year) graft outcome and for considering retransplantation in a timely fashion. (c) 2007 AASLD.

Entities:  

Mesh:

Year:  2007        PMID: 17969209     DOI: 10.1002/lt.21345

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  5 in total

1.  Incidence and risk factors for early renal dysfunction after liver transplantation.

Authors:  Patricia Wiesen; Paul B Massion; Jean Joris; Olivier Detry; Pierre Damas
Journal:  World J Transplant       Date:  2016-03-24

2.  The outcomes of patients with severe hyperbilirubinemia following living donor liver transplantation.

Authors:  Hajime Matsushima; Akihiko Soyama; Mitsuhisa Takatsuki; Masaaki Hidaka; Izumi Muraoka; Tamotsu Kuroki; Susumu Eguchi
Journal:  Dig Dis Sci       Date:  2013-01-12       Impact factor: 3.199

3.  Early Allograft Dysfunction After Live Donor Liver Transplantation: It's Time to Redefine?

Authors:  Viniyendra Pamecha; Bramhadatta Pattnaik; Piyush K Sinha; Nilesh S Patil; Shridhar V Sasturkar; Nihar Mohapatra; Guresh Kumar; Ashok Choudhury; Shiv K Sarin
Journal:  J Clin Exp Hepatol       Date:  2021-03-30

4.  "Real-time" risk models of postoperative morbidity and mortality for liver transplants.

Authors:  Shigeru Marubashi; Naoaki Ichihara; Yoshihiro Kakeji; Hiroaki Miyata; Akinobu Taketomi; Hiroto Egawa; Yasutsugu Takada; Koji Umeshita; Yasuyuki Seto; Mitsukazu Gotoh
Journal:  Ann Gastroenterol Surg       Date:  2018-11-02

5.  Estrogen-Estrogen Receptor α Signaling Facilitates Bilirubin Metabolism in Regenerating Liver Through Regulating Cytochrome P450 2A6 Expression.

Authors:  Ta-Lun Kao; Yao-Li Chen; Yu-Ping Kuan; Wei-Chun Chang; Yu-Chen Ho; Shuyuan Yeh; Long-Bin Jeng; Wen-Lung Ma
Journal:  Cell Transplant       Date:  2017-11       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.